1056 related articles for article (PubMed ID: 33675822)
1. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway.
Xu X; Huang X; Zhang L; Huang X; Qin Z; Hua F
BMC Nephrol; 2021 Jun; 22(1):218. PubMed ID: 34107901
[TBL] [Abstract][Full Text] [Related]
3. Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis.
Fu R; Guo C; Wang S; Huang Y; Jin O; Hu H; Chen J; Xu B; Zhou M; Zhao J; Sung SJ; Wang H; Gaskin F; Yang N; Fu SM
Arthritis Rheumatol; 2017 Aug; 69(8):1636-1646. PubMed ID: 28544564
[TBL] [Abstract][Full Text] [Related]
4. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
[TBL] [Abstract][Full Text] [Related]
5. Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway.
Yu Q; Zhang M; Qian L; Wen D; Wu G
Life Sci; 2019 May; 225():1-7. PubMed ID: 30935950
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms.
Dolunay A; Senol SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S; Tunctan B
Inflammation; 2017 Apr; 40(2):366-386. PubMed ID: 27924425
[TBL] [Abstract][Full Text] [Related]
7. A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease.
Huang S; Chen Z; Fan B; Chen Y; Zhou L; Jiang B; Long H; Zhong W; Li X; Li Y
J Neuroimmunol; 2021 May; 354():577543. PubMed ID: 33714750
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
[TBL] [Abstract][Full Text] [Related]
9. Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease.
Østergaard JA; Jha JC; Sharma A; Dai A; Choi JSY; de Haan JB; Cooper ME; Jandeleit-Dahm K
Clin Sci (Lond); 2022 Jan; 136(2):167-180. PubMed ID: 35048962
[TBL] [Abstract][Full Text] [Related]
10. A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation.
Zhang C; Zhu X; Li L; Ma T; Shi M; Yang Y; Fan Q
Diabetes Metab Syndr Obes; 2019; 12():1297-1309. PubMed ID: 31447572
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death.
Matsuoka T; Yoshimatsu G; Sakata N; Kawakami R; Tanaka T; Yamada T; Yoshida Y; Hasegawa S; Kodama S
Sci Rep; 2020 Oct; 10(1):17920. PubMed ID: 33087823
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
13. Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome.
Wang B; Dai Z; Gao Q; Liu Y; Gu G; Zheng H
Biochem Biophys Res Commun; 2022 Feb; 594():131-138. PubMed ID: 35081502
[TBL] [Abstract][Full Text] [Related]
14. Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation.
Huang D; Kidd JM; Zou Y; Wu X; Li N; Gehr TWB; Li PL; Li G
Am J Physiol Renal Physiol; 2024 Jun; 326(6):F988-F1003. PubMed ID: 38634138
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.
Hou Y; Lin S; Qiu J; Sun W; Dong M; Xiang Y; Wang L; Du P
Biochem Biophys Res Commun; 2020 Jan; 521(3):791-798. PubMed ID: 31703838
[TBL] [Abstract][Full Text] [Related]
16. The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages.
Finucane OM; Sugrue J; Rubio-Araiz A; Guillot-Sestier MV; Lynch MA
Sci Rep; 2019 Mar; 9(1):4034. PubMed ID: 30858427
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model.
Sui A; Chen X; Shen J; Demetriades AM; Yao Y; Yao Y; Zhu Y; Shen X; Xie B
Cell Death Dis; 2020 Oct; 11(10):901. PubMed ID: 33093455
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-
He J; Cui J; Shi Y; Wang T; Xin J; Li Y; Shan X; Zhu Z; Gao Y
J Diabetes Res; 2023; 2023():7423661. PubMed ID: 37261217
[TBL] [Abstract][Full Text] [Related]
19. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J
Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NLRP3 Inflammasome Ameliorates Cerebral Ischemia-Reperfusion Injury in Diabetic Mice.
Hong P; Li FX; Gu RN; Fang YY; Lai LY; Wang YW; Tao T; Xu SY; You ZJ; Zhang HF
Neural Plast; 2018; 2018():9163521. PubMed ID: 29853850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
